Srinivas Akkaraju - 04 Sep 2026 Form 4 Insider Report for ALUMIS INC. (ALMS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 Sep 2026, 21:39:48 UTC
Prior SEC filing
02 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Srinivas Akkaraju

Key filing fact

Srinivas Akkaraju filed Form 4 for ALUMIS INC. (ALMS) on 09 Sep 2026.

Key facts

  • This page summarizes Srinivas Akkaraju's Form 4 filing for ALUMIS INC. (ALMS).
  • 6 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Sep 2026, 21:39.

Change

  • Previous filing in this sequence was filed on 02 Jul 2026.
  • Current net transaction value: +$9,712,227.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001253170 Primary reporting owner

AKKARAJU SRINIVAS

Relationship
Director
Address
C/O ALUMIS INC., 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Signature
/s/ Srinivas Akkaraju
Signature date
09 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALMS transaction

Common Stock

Purchase

Transaction value
$2,458,842
Shares
+220,070
Change %
+4.9%
Price
$11.17
Shares after
4,711,801
Date
04 Sep 2026
Ownership
By Samsara BioCapital, L.P.
Footnotes
F1, F2
ALMS transaction

Common Stock

Purchase

Transaction value
$2,458,842
Shares
+220,070
Change %
+12%
Price
$11.17
Shares after
2,073,558
Date
04 Sep 2026
Ownership
By Samsara Opportunity Fund, L.P.
Footnotes
F1, F3
ALMS transaction

Common Stock

Sale

Transaction value
$507,019
Shares
-48,066
Change %
-1%
Price
$10.55
Shares after
4,663,735
Date
08 Sep 2026
Ownership
By Samsara BioCapital, L.P.
Footnotes
F2, F4, F5
ALMS transaction

Common Stock

Sale

Transaction value
$507,009
Shares
-48,065
Change %
-2.3%
Price
$10.55
Shares after
2,025,493
Date
08 Sep 2026
Ownership
By Samsara Opportunity Fund, L.P.
Footnotes
F3, F4, F5
ALMS transaction

Common Stock

Purchase

Transaction value
$2,904,291
Shares
+273,291
Change %
+5.9%
Price
$10.63
Shares after
4,937,026
Date
08 Sep 2026
Ownership
By Samsara BioCapital, L.P.
Footnotes
F2, F4, F6
ALMS transaction

Common Stock

Purchase

Transaction value
$2,904,280
Shares
+273,290
Change %
+13%
Price
$10.63
Shares after
2,298,783
Date
08 Sep 2026
Ownership
By Samsara Opportunity Fund, L.P.
Footnotes
F3, F4, F6
ALMS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,553
Date
04 Sep 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $11.02 to $11.60, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

Footnote F2

Shares are directly held by Samsara BioCapital LP. ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Footnote F3

Shares are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.

Footnote F4

The sales and purchases on September 8, 2026 were matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 48,066 shares in the case of Samsara LP and 48,065 shares in the case of Samsara Opportunity Fund, resulting in short-swing profit liability under Section 16(b). The Reporting Person has agreed to disgorge to the Issuer the short-swing profit realized in connection with these transactions, less transaction costs.

Footnote F5

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $10.38 to $10.91, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Footnote F6

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $10.26 to $10.835, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .